NCT03834571 2022-06-21
Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women
AIDS Malignancy Consortium
Phase 2 Withdrawn
Clinical Trials
20 trialsNCT01266460 2020-09-11
Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00331760 2019-02-26
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00309959 2019-01-08
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00041093 2018-01-10
Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00691301 2018-01-09
Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00039442 2017-08-24
Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT02501278 2016-05-13
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn
NCT00217633 2015-05-29
Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00101192 2014-03-17
Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00087113 2014-02-14
Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
GOG Foundation
Phase 2 Completed
NCT00002478 2013-06-10
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
GOG Foundation
Phase 2 Terminated
NCT00002813 2013-05-27
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00016926 2013-05-27
Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00276796 2013-05-27
Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00003624 2013-04-11
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
GOG Foundation
Phase 2 Terminated
NCT00006224 2013-04-11
Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
GOG Foundation
Phase 2 Terminated
NCT00006482 2013-04-11
Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
GOG Foundation
Phase 2 Terminated
NCT00002916 2012-07-02
Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00003369 2012-06-14
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
SWOG Cancer Research Network
Phase 2 Completed